MYFORTIC 360MG TABLET
| Product Name | Myfortic 360mg Tablet |
| Composition | Mycophenolic Acid 360mg |
| Form | Tablet |
| Category | Immunosuppressant |
| Indications | Prevention of organ rejection after kidney transplant |
| Dosage | As prescribed by transplant specialist |
| Packaging | Strip or bottle pack |
| Storage | Store below 25Β°C in a dry place |
MYFORTIC 360MG TABLET
Myfortic 360mg Tablet is an immunosuppressant medicine used to prevent organ rejection in patients who have undergone kidney transplantation. It contains Mycophenolic Acid, which works by reducing the activity of the immune system so it does not attack the transplanted organ. Myfortic is commonly prescribed along with other transplant medicines such as corticosteroids and calcineurin inhibitors.
Myfortic 360mg Tablet helps lower the risk of acute rejection by blocking the growth of certain immune cells that damage the new organ. It plays a key role in improving long-term transplant outcomes and maintaining proper kidney function. Regular medical monitoring is essential during treatment to adjust dosage and manage any possible side effects.
Myfortic 360mg Tablet should be taken exactly as directed by a transplant specialist. Consistent use is important for protecting the transplanted organ and ensuring successful recovery. Patients must attend regular follow-ups and follow medical advice carefully for safe and effective treatment.
Product Features
- Contains Mycophenolic Acid 360mg
- Prevents organ rejection after kidney transplant
- Used in combination immunosuppressive therapy
- Supports long-term transplant success
- Requires regular medical monitoring
How It Helps
- Suppresses immune response after transplant
- Prevents rejection of the transplanted kidney
- Improves transplant survival outcomes
- Maintains proper organ function





Reviews
There are no reviews yet.